{"id":"https://openalex.org/W4362393577","doi":"https://doi.org/10.1158/1078-0432.22444265","title":"Supplementary Figure 2 from Development and Characterization of a Novel CD19CherryLuciferase (CD19CL) Transgenic Mouse for the Preclinical Study of B-Cell Lymphomas","display_name":"Supplementary Figure 2 from Development and Characterization of a Novel CD19CherryLuciferase (CD19CL) Transgenic Mouse for the Preclinical Study of B-Cell Lymphomas","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4362393577","doi":"https://doi.org/10.1158/1078-0432.22444265"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22444265","doi":"https://doi.org/10.1158/1078-0432.22444265","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22444265","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Development_and_Characterization_of_a_Novel_CD19CherryLuciferase_CD19CL_Transgenic_Mouse_for_the_Preclinical_Study_of_B-Cell_Lymphomas/22444265/1/files/39895298.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Development_and_Characterization_of_a_Novel_CD19CherryLuciferase_CD19CL_Transgenic_Mouse_for_the_Preclinical_Study_of_B-Cell_Lymphomas/22444265/1/files/39895298.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016848239","display_name":"Luigi Scotto","orcid":"https://orcid.org/0000-0002-7071-926X","observed_orcids":["https://orcid.org/0000-0002-7071-926X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luigi Scotto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032290331","display_name":"Marianna Kruithof\u2010de Julio","orcid":"https://orcid.org/0000-0002-6085-7706","observed_orcids":["https://orcid.org/0000-0002-6085-7706"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marianna Kruithof-de Julio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062618199","display_name":"Luca Paoluzzi","orcid":"https://orcid.org/0000-0002-2656-5224","observed_orcids":["https://orcid.org/0000-0002-2656-5224"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luca Paoluzzi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053153501","display_name":"Matko Kalac","orcid":"https://orcid.org/0000-0003-1238-0760","observed_orcids":["https://orcid.org/0000-0003-1238-0760"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matko Kalac","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102738050","display_name":"Enrica Marchi","orcid":"https://orcid.org/0000-0002-6661-9119","observed_orcids":["https://orcid.org/0000-0002-6661-9119"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Enrica Marchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086916698","display_name":"Jairo Baquero Buitrago","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jairo Baquero Buitrago","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075692970","display_name":"Jennifer Effie Amengual","orcid":"https://orcid.org/0000-0003-4117-2469","observed_orcids":["https://orcid.org/0000-0003-4117-2469"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer Amengual","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025125161","display_name":"Michael M. Shen","orcid":"https://orcid.org/0000-0002-4042-1657","observed_orcids":["https://orcid.org/0000-0002-4042-1657"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael M. Shen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5002126535","display_name":"Owen A. O\u2019Connor","orcid":"https://orcid.org/0000-0002-5631-0011","observed_orcids":["https://orcid.org/0000-0002-5631-0011"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Owen A. O'Connor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.7958999872207642,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.7958999872207642,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.1282999962568283,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.024900000542402267,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd19","display_name":"CD19","score":0.8240000009536743},{"id":"https://openalex.org/keywords/transgenic-mice","display_name":"transgenic mice","score":0.8500000238418579},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.949999988079071},{"id":"https://openalex.org/keywords/splenic-histology","display_name":"spleen histology","score":0.7070000171661377},{"id":"https://openalex.org/keywords/lymph-node-pathology","display_name":"lymph node histopathology","score":0.9240000247955322},{"id":"https://openalex.org/keywords/h-e-staining","display_name":"H&E staining","score":0.7950000166893005},{"id":"https://openalex.org/keywords/preclinical-models","display_name":"preclinical models","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C125473707","wikidata":"https://www.wikidata.org/wiki/Q9914","display_name":"H&E stain","level":3,"score":0.7961112260818481},{"id":"https://openalex.org/C141035611","wikidata":"https://www.wikidata.org/wiki/Q5532934","display_name":"Genetically modified mouse","level":4,"score":0.7878729104995728},{"id":"https://openalex.org/C102230213","wikidata":"https://www.wikidata.org/wiki/Q430117","display_name":"Transgene","level":3,"score":0.6420137286186218},{"id":"https://openalex.org/C2780931953","wikidata":"https://www.wikidata.org/wiki/Q9371","display_name":"Spleen","level":2,"score":0.5446483492851257},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.5435265898704529},{"id":"https://openalex.org/C2779720271","wikidata":"https://www.wikidata.org/wiki/Q179422","display_name":"Lymph","level":2,"score":0.5238321423530579},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.47111061215400696},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4432346820831299},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3110511302947998},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.25810277462005615},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2328920066356659},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.16216808557510376},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.16191375255584717},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.11537313461303711},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06877738237380981}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22444265","doi":"https://doi.org/10.1158/1078-0432.22444265","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22444265","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Development_and_Characterization_of_a_Novel_CD19CherryLuciferase_CD19CL_Transgenic_Mouse_for_the_Preclinical_Study_of_B-Cell_Lymphomas/22444265/1/files/39895298.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22444265.v1","doi":"https://doi.org/10.1158/1078-0432.22444265.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22444265.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22444265","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Development_and_Characterization_of_a_Novel_CD19CherryLuciferase_CD19CL_Transgenic_Mouse_for_the_Preclinical_Study_of_B-Cell_Lymphomas/22444265","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22444265","doi":"https://doi.org/10.1158/1078-0432.22444265","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22444265","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Development_and_Characterization_of_a_Novel_CD19CherryLuciferase_CD19CL_Transgenic_Mouse_for_the_Preclinical_Study_of_B-Cell_Lymphomas/22444265/1/files/39895298.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W4362393577.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361944300","https://openalex.org/W2160295522","https://openalex.org/W2591217280","https://openalex.org/W4206929224","https://openalex.org/W2031140357","https://openalex.org/W2558466213","https://openalex.org/W2136374191","https://openalex.org/W4234629388","https://openalex.org/W7096621715","https://openalex.org/W4210974188"],"abstract_inverted_index":{"PDF":[0],"file,":[1],"1117KB,":[2],"Histologic":[3],"analysis":[4],"of":[5,21,24],"CD19cherryluciferase":[6],"transgenic":[7],"mice.":[8],"Sections":[9],"are":[10],"from":[11,18],"(a-c)":[12],"spleen":[13],"and":[14,27],"(b-d)":[15],"lymph":[16],"nodes":[17],"a":[19],"mouse":[20],"three":[22],"months":[23],"age.":[25],"Hematoxylin":[26],"eosin":[28],"(a-b)":[29],"X20":[30],"(c-d)":[31],"or":[32],"X40.":[33]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}